These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11837251)
41. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159 [TBL] [Abstract][Full Text] [Related]
42. Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Divakar S; Saravanan K; Karthikeyan P; Elancheran R; Kabilan S; Balasubramanian KK; Devi R; Kotoky J; Ramanathan M Chem Biol Interact; 2017 Sep; 275():22-34. PubMed ID: 28757136 [TBL] [Abstract][Full Text] [Related]
43. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Kokontis JM; Hay N; Liao S Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399 [TBL] [Abstract][Full Text] [Related]
44. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo. Petiwala SM; Li G; Bosland MC; Lantvit DD; Petukhov PA; Johnson JJ Carcinogenesis; 2016 Aug; 37(8):827-838. PubMed ID: 27267997 [TBL] [Abstract][Full Text] [Related]
45. Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP. Zhao H; Zhu C; Qin C; Tao T; Li J; Cheng G; Li P; Cao Q; Meng X; Ju X; Shao P; Hua L; Gu M; Yin C Biochem Biophys Res Commun; 2013 Mar; 432(2):320-5. PubMed ID: 23399562 [TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Lu S; Tsai SY; Tsai MJ Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131 [TBL] [Abstract][Full Text] [Related]
47. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301 [TBL] [Abstract][Full Text] [Related]
48. Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A. Yu DS; Hsieh DS; Chang SY J Urol; 2003 Nov; 170(5):2031-5. PubMed ID: 14532847 [TBL] [Abstract][Full Text] [Related]
49. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269 [TBL] [Abstract][Full Text] [Related]
50. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
51. Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells. Xu H; Yu X; Qu S; Sui D Bioorg Med Chem Lett; 2013 Jun; 23(12):3631-4. PubMed ID: 23643730 [TBL] [Abstract][Full Text] [Related]
52. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Kan SF; Huang WJ; Lin LC; Wang PS Int J Cancer; 2004 Jul; 110(5):641-51. PubMed ID: 15146552 [TBL] [Abstract][Full Text] [Related]
53. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
54. Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells. Moon HS; Lim H; Moon S; Oh HL; Kim YT; Kim MK; Lee CH Bioorg Med Chem Lett; 2009 Feb; 19(3):742-4. PubMed ID: 19119006 [TBL] [Abstract][Full Text] [Related]
55. Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells. Huang DM; Shen YC; Wu C; Huang YT; Kung FL; Teng CM; Guh JH Eur J Pharmacol; 2004 Oct; 503(1-3):17-24. PubMed ID: 15496290 [TBL] [Abstract][Full Text] [Related]
56. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma. Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of cell growth and induction of apoptosis in human prostate cancer cell lines by 6-aminoquinolone WM13. Minelli A; Bellezza I; Siciliano E; Liguori L; Tabarrini O; Cecchetti V; Fravolini A Oncol Rep; 2005 Jun; 13(6):1113-20. PubMed ID: 15870930 [TBL] [Abstract][Full Text] [Related]